Christi Shaw is Director of Avantor, Inc.. Currently has a direct ownership of 36,271 shares of AVTR, which is worth approximately $769,307. The most recent transaction as insider was on May 11, 2023, when has been sold 9,808 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.3K
0% 3M change
0% 12M change
Total Value Held $769,307

Christi Shaw Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 11 2023
BUY
Grant, award, or other acquisition
-
9,808 Added 21.29%
36,271 Common Stock
May 12 2022
BUY
Grant, award, or other acquisition
-
6,693 Added 20.19%
26,463 Common Stock
Apr 01 2022
BUY
Grant, award, or other acquisition
-
1,215 Added 5.79%
19,770 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
7,236 Added 28.06%
18,555 Common Stock
Dec 11 2020
SELL
Open market or private sale
$381,150 $26.68 p/Share
14,286 Reduced 55.79%
11,319 Common Stock

Also insider at

BEAM
Beam Therapeutics Inc. Healthcare
LLY
ELI LILLY & Co Healthcare
KYTX
Kyverna Therapeutics, Inc.
CS

Christi Shaw

Director
Indianapolis, IN

Track Institutional and Insider Activities on AVTR

Follow Avantor, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTR shares.

Notify only if

Insider Trading

Get notified when an Avantor, Inc. insider buys or sells AVTR shares.

Notify only if

News

Receive news related to Avantor, Inc.

Track Activities on AVTR